NOT KNOWN DETAILS ABOUT TARLOX-TKI

The phylogenetic map with the human kinome demonstrating improvement and US FDA acceptance of compact molecule kinase inhibitors to tyrosine kinases and serine/threonine kinases for various good and hematologic malignancies.The breathtaking results demonstrated with imatinib mesylate (aka Gleevec) targeting break place cluster (Bcr)-Abelson (Abl) f